Company profile
Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments. The company develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. It also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercially available MRS pulse sequences in scanning
- CEO
- Mr. Brent Ness
- Headquarters
- Broomfield, CO, United States
- Employees
- 10
- IPO date
- Apr 22, 2022
- Sector
- —
- Industry
- Health Care Equipment & Supplies